Akzo Nobel N V ADR (AKZOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 2,792,574 | 2,781,742 | 2,977,188 | 2,981,035 | 2,752,795 |
| Cost of Goods | 1,647,923 | 1,683,569 | 1,776,728 | 1,802,698 | 1,648,728 |
| Gross Profit | 1,144,651 | 1,098,172 | 1,200,460 | 1,178,338 | 1,104,068 |
| Operating Expenses | 938,414 | 193,100 | 1,235,086 | 936,102 | 902,523 |
| Operating Income | 207,161 | 905,643 | -33,898 | 242,933 | 202,272 |
| Interest Expense | 43,305 | 104,707 | 88,836 | 0 | 31,605 |
| Other Income | 9,363 | 59,174 | 10,520 | -39,732 | 7,375 |
| Pre-tax Income | 173,219 | 860,109 | -112,214 | 203,201 | 178,042 |
| Income Tax | 55,009 | 158,443 | 109,877 | 49,949 | 50,568 |
| Net Income Continuous | 118,210 | 701,666 | -222,091 | 153,252 | 127,474 |
| Net Income Discontinuous | N/A | 38 | -1,169 | N/A | N/A |
| Minority Interests | 9,363 | 9,988 | 3,507 | 12,487 | 14,749 |
| Net Income | $108,847 | $691,716 | $-226,767 | $140,765 | $112,725 |
| EPS Basic Total Ops | 0.21 | 1.34 | -0.44 | 0.28 | 0.22 |
| EPS Basic Continuous Ops | 0.23 | 1.37 | -0.43 | 0.30 | 0.25 |
| EPS Diluted Total Ops | 0.21 | 1.34 | -0.44 | 0.28 | 0.22 |
| EPS Diluted Continuous Ops | 0.23 | 1.37 | -0.43 | 0.30 | 0.25 |
| EPS Diluted Before Non-Recurring Items | 0.35 | 0.22 | 0.39 | 0.43 | 0.33 |
| EBITDA(a) | $316,008 | $1,006,019 | $82,247 | $355,051 | $301,301 |